Form 4 for CDLX Cardlytics, Inc.
Accepted 2023-09-05 00:00:00 ET · period of report 2023-09-01 · accession 0001666071-23-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-05 | 2023-09-01 | CDLX | Temsamani Karim Saad | CEO, Dir | M - OptEx | $0.00 | +336.3K | 360.7K | +1,377% | $0 |
| D | 2023-09-05 | 2023-09-01 | CDLX | Temsamani Karim Saad | CEO, Dir | M - OptEx | $0.00 | -336.3K | 1.01M | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-01 | M | A | 336,315 | $0.00 | 360,741 | D | — | — | (F1) Represents the underlying vested shares of common stock of the Issuer. |
| 2 | Derivative | Restricted Stock Unit | 2023-09-01 | M | D | 336,315 | $0.00 | 1,008,946 | D | — · — to — | 336,315 Common Stock | (F2) Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. (F3) 25% of the RSUs vested on September 1, 2023 with the remaining 75% vesting in equal amounts over the subsequent three years quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date. |